Literature DB >> 11940586

Ligand specificity and conformational dependence of the hepatic nuclear factor-4alpha (HNF-4alpha ).

Anca D Petrescu1, Rachel Hertz, Jacob Bar-Tana, Friedhelm Schroeder, Ann B Kier.   

Abstract

Hepatic nuclear factor-4alpha (HNF-4alpha) controls the expression of genes encoding proteins involved in lipid and carbohydrate metabolism. Fatty acyl-CoA thioesters have recently been proposed to be naturally occurring ligands of HNF-4alpha and to regulate its transcriptional activity as function of their chain length and degree of unsaturation (Hertz, R., Magenheim, J., Berman, I., and Bar-Tana, J. (1998) Nature 392, 512-516). However, the apparent low affinities (microm K(d) values) obtained with a radiolabeled fatty acyl-CoA ligand binding assay raised questions regarding the physiological significance of this finding. Furthermore, it is not known whether interaction with fatty acyl-CoA alters the structure of HNF-4alpha. These issues were examined using rat recombinant HNF-4alpha ligand-binding domain (HNF-4alphaLBD) in conjunction with photon counting fluorescence and circular dichroism. First, fluorescence resonance energy transfer between HNF-4alphaLBD tryptophan (Trp) and cis-parinaroyl-CoA yielded an intermolecular distance of <or=42 A, thus pointing to direct molecular interaction rather than nonspecific coaggregation. Second, quenching of HNF-4alphaLBD intrinsic Trp fluorescence by fatty acyl-CoAs (e.g. pamitoyl-, stearoyl-, linoleoyl-, and arachidonoyl-CoAs) yielded a single binding site with K(d) values of 1.6-4.0 nm. These affinities were 2-3 orders of magnitude higher than those previously derived by radiolabeled fatty acyl-CoA ligand binding assay. Third, binding of fatty acyl-CoAs was specific as the binding affinities of the respective free fatty acids or free CoA (K(d) values of 421-742 nm) were significantly lower. Fourth, circular dichroism demonstrated that the HNF-4alphaLBD secondary structure was significantly and differentially altered by fatty acyl-CoA binding. The opposite effects of saturated versus polyunsaturated fatty acyl-CoAs on HNF-4alpha LBD secondary structure correlated with their opposite regulatory effects on HNF-4alpha function. Fifth, the CoA thioesters of some hypolipidemic peroxisome proliferators bind with high affinity (K(d) values as low as 2.6 nm) to HNF-4alpha LBD, thus indicating that HNF-4alpha may serve as target for these drugs. In summary, these data demonstrate for the first time high affinity binding to HNF-4alpha of fatty and xenobiotic acyl-CoAs in the physiological range, resulting in significantly altered HNF-4alpha conformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940586     DOI: 10.1074/jbc.M201241200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).

Authors:  Jason M Fritzler; Guan Zhu
Journal:  J Antimicrob Chemother       Date:  2011-12-13       Impact factor: 5.790

2.  Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells.

Authors:  Valérie Marcil; Ernest Seidman; Daniel Sinnett; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Louis-Philippe Precourt; Devendra Amre; Emile Levy
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

3.  A single amino acid change humanizes long-chain fatty acid binding and activation of mouse peroxisome proliferator-activated receptor α.

Authors:  Dhawal P Oswal; Gerald M Alter; S Dean Rider; Heather A Hostetler
Journal:  J Mol Graph Model       Date:  2014-04-29       Impact factor: 2.518

4.  Negative autoregulation of HNF-4alpha gene expression by HNF-4alpha1.

Authors:  Judith Magenheim; Rachel Hertz; Ina Berman; Janna Nousbeck; Jacob Bar-Tana
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

5.  Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.

Authors:  Friedhelm Schroeder; Huan Huang; Heather A Hostetler; Anca D Petrescu; Rachel Hertz; Jacob Bar-Tana; Ann B Kier
Journal:  Lipids       Date:  2005-06       Impact factor: 1.880

6.  Fluorescent sterols monitor cell penetrating peptide Pep-1 mediated uptake and intracellular targeting of cargo protein in living cells.

Authors:  Anca D Petrescu; Aude Vespa; Huan Huang; Avery L McIntosh; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta       Date:  2008-10-17

7.  HNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter.

Authors:  Alice Kiselyuk; Seung-Hee Lee; Suzette Farber-Katz; Mingjun Zhang; Sonalee Athavankar; Tom Cohen; Anthony B Pinkerton; Mao Ye; Paul Bushway; Adam D Richardson; Heather A Hostetler; Mariam Rodriguez-Lee; Li Huang; Benjamin Spangler; Layton Smith; Jennifer Higginbotham; John Cashman; Hudson Freeze; Pamela Itkin-Ansari; Marcia I Dawson; Friedhelm Schroeder; Yong Cang; Mark Mercola; Fred Levine
Journal:  Chem Biol       Date:  2012-07-27

8.  Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4alpha. Diabetes gene product.

Authors:  Peng Lu; Geun Bae Rha; Manana Melikishvili; Guangteng Wu; Brandon C Adkins; Michael G Fried; Young-In Chi
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

9.  Identification and characterization of the flavin:NADH reductase (PrnF) involved in a novel two-component arylamine oxygenase.

Authors:  Jung-Kul Lee; Huimin Zhao
Journal:  J Bacteriol       Date:  2007-10-05       Impact factor: 3.490

10.  A Prospero-related homeodomain protein is a novel co-regulator of hepatocyte nuclear factor 4alpha that regulates the cholesterol 7alpha-hydroxylase gene.

Authors:  Kwang-Hoon Song; Tiangang Li; John Y L Chiang
Journal:  J Biol Chem       Date:  2006-02-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.